Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(44 sites)

United States

Research Site, Los Angeles, California

Research Site, Baton Rouge, Louisiana

Research Site, Grand Rapids, Michigan

Research Site, New Hyde Park, New York

Research Site, New York, New York

Research Site, Shirley, New York

Research Site, The Bronx, New York

Research Site, Pittsburgh, Pennsylvania

China

Research Site, Beijing

Research Site, Hangzhou

Research Site, Harbin

Research Site, Hefei

Research Site, Kunming

Research Site, Wuhan

Research Site, Yinchuan

Research Site, Zhengzhou

Japan

Research Site, Chūōku

Research Site, Kashiwa

Research Site, Sunto-gun

South Korea

Research Site, Seoul

Spain

Research Site, Barcelona

Research Site, Elche(Alicante)

Research Site, L'Hospitalet de Llobregat

Research Site, Madrid

Research Site, Santander

Taiwan

Research Site, Hsinchu

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan

Research Site, Taipei

Research Site, Taoyuan District

United Kingdom

Research Site, Edinburgh

Research Site, Leeds

Research Site, London

Research Site, Oxford